- David has co-founded more than 20 companies across life sciences and sustainability, including Valo, where he serves as CEO
- He has served as founding CEO of over 10 companies including, Seres Therapeutics (NASDAQ: MCRB), Evelo Biosciences (NASDAQ: EVLO), and Axcella Health
- David played an instrumental role in the conception and implementation of Flagship Labs, which is the foundation of all of its companies
- He has been broadly recognized as a world-leading innovator: elected as a Young Global Leader by the World Economic Forum, named as Innovator of the Year by MIT Technology Review, and selected as one of 12 Innovators Reshaping Reality by the U.S. State Department
- David currently serves on the United Nations Sustainable Development Solutions Network (UN SDSN), where he was a Founding Leadership Council Member
- MD from Harvard Medical School and PhD from MIT in Biological Engineering completing the fastest dual degree in the modern history of the program
-
David Berry, MD
General Partner at Flagship Pioneering, Founder & CEO at Valo
David Berry, MD
Go To LinkedIn -
Deepa Pakianathan, Ph.D.
Managing Member, Delphi Ventures
Deepa Pakianathan, Ph.D.
Go To LinkedIn- Deepa is a Managing Member at Delphi Ventures and leads all of the firm’s biotechnology investment activities
- While at Delphi, Deepa has funded 11 drugs that are on the market helping patients including three that generate over $1b in revenue each
- Her current and previous experience on the boards includes Alder Biopharmaceuticals (Nasdaq:ALDR), Calithera Biosciences (Nasdaq:CALA), Karyopharm Therapeutics (Nasdaq:KPTI), Oncomed Pharmaceuticals (Nasdaq:OMED), PTC Therapeutics (Nasdaq:PTCT) and others. She also led the investments in Cardeas Pharma, KAI Pharmaceuticals (acquired by Amgen), and a PIPE investment in Seattle Genetics (Nasdaq:SGEN)
- Deepa’s previous experience includes a Vice President role in the healthcare group at J.P. Morgan where she was involved in several large healthcare M&A transactions and led public offerings for biotechnology companies that raised over $9b. Before that, she was a biotechnology research analyst at Genesis Merchant Group. She worked as a postdoctoral scientist in the Immunology Department at Genentech Corporation from 1993 to 1997
- She serves as Vice-Chair of the San Francisco Conservatory of Music’s Board of Trustees
- Deepa received her Ph.D. and MS from Wake Forest University and her MSc and BSc from the University of Bombay
-
